Reply to Gargiulo et al.: Dose-stratified real-world effectiveness of JAK1 inhibitors in atopic dermatitis [0.03%]
对Gargiulo等人的答复：JAK1抑制剂在特应性皮炎中的剂量分层的真实世界疗效
Abdullah Demirbaş,Mustafa Esen,Esin Diremsizoglu et al.
Abdullah Demirbaş et al.
Maintenance management after dupilumab discontinuation in moderate-to-severe atopic dermatitis: a comparative study of proactive intermittent tacrolimus and reactive rescue therapy [0.03%]
度普利尤单抗停药后中重度特应性皮炎的维持管理：前瞻性间歇使用他克莫司与按需补救治疗的比较研究
Yan Tang,Zaibing Li
Yan Tang
Background: Moderate-to-severe atopic dermatitis (AD) often relapses after dupilumab discontinuation. This study compared proactive intermittent tacrolimus versus on-demand therapy for post-discontinuation maintenance. ...
Observational Study
The Journal of dermatological treatment. 2026 Dec;37(1):2629102. DOI:10.1080/09546634.2026.2629102 2026
Sociodemographic, clinical, and behavioral determinants of treatment adherence in acne vulgaris: a multicenter study [0.03%]
寻常痤疮治疗依从性的社会人口学、临床及行为影响因素的多中心研究
Arzu Ferhatosmanoğlu,İbrahim Etem Arıca,Mualla Polat et al.
Arzu Ferhatosmanoğlu et al.
Background: This multicenter study aimed to evaluate treatment adherence and satisfaction among patients with acne vulgaris. Methods: A...
Application of a subcutaneous tissue pedicle flap combined with a labial mucosa flap for reconstruction of full-thickness lower lip defects: a prospective observational study [0.03%]
下唇全层缺损修复中应用皮下组织瓣联合唇粘膜瓣的临床观察研究
Jianbo Chen,Zhibing Fu,Yifei Xie et al.
Jianbo Chen et al.
Background: Reconstruction of full-thickness lower-lip defects after skin cancer excision is challenging, as both oral function and appearance must be restored. Conventional methods may be insufficient for moderate-sized ...
Observational Study
The Journal of dermatological treatment. 2026 Dec;37(1):2617778. DOI:10.1080/09546634.2026.2617778 2026
Dose escalation and personalization in atopic dermatitis: reply to the real-world study by Demirbaş et al. " Dose-dependent effectiveness and patient-reported outcomes with JAK1 inhibitors in atopic dermatitis: a 36-week multicenter real-world cohort." [0.03%]
关于Demirbaș等人的实际研究的回复"针对特应性皮炎使用JAK1抑制剂的效果和患者报告结果：一项为期36周的多中心真实世界队列研究"中的剂量递增与个性化治疗答复
Luigi Gargiulo,Matteo Bianco,Luciano Ibba et al.
Luigi Gargiulo et al.
Julia Sternicka-Rohde,Leszek Bieniaszewski,Roman J Nowicki et al.
Julia Sternicka-Rohde et al.
Objectives: Off-label prescribing is a common and often necessary practice in dermatology, as approved treatment options frequently fail to meet the diverse needs of patients. This is particularly relevant in the manageme...
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study [0.03%]
GULLIVER研究： Guselkumab治疗成人面部和/或生殖器银屑病的有效性和安全性：一项为期52周的意大利多中心研究分析
Claudio Bonifati,Giuseppe Argenziano,Serena Lembo et al.
Claudio Bonifati et al.
Objectives: Facial and genital plaques are common manifestations of psoriasis, are challenging to treat, and significantly impact patients' quality of life (QoL). ...
24-week real world outcomes of nemolizumab in patients with prurigo nodularis [0.03%]
Nemolizumab治疗痒疹的疗效和安全性：真实世界研究
Yoshihito Mima,Masako Yamamoto,Ken Iozumi
Yoshihito Mima
Backgrounds: Prurigo nodularis (PN) is a chronic pruritic inflammatory disease associated with immune and neural dysregulation. Although nemolizumab has demonstrated efficacy in clinical trials, real-world post-marketing ...
Evidence-based recommendations for the treatment of recurrent aphthous stomatitis: insights from an umbrella review [0.03%]
复发性阿弗他溃疡治疗的循证推荐：综合审阅的新见解
Nader A Al-Aizari,Hashem M Al-Shamiri,Bayan K AlShehri et al.
Nader A Al-Aizari et al.
Objective: To compare the effectiveness and safety of pharmacological, physical, and complementary interventions for recurrent aphthous stomatitis (RAS) across clinically relevant outcomes. ...